Drug recall · April 1, 2020
Theophylline recall
Why: CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.
- Lots / codes
Lot: THE190501, Exp 11/2022
- Quantity
- 4722 bottles
- Company
- Nostrum Laboratories Inc, Kansas City, MO
- Distribution
- TN, MO
- Initiated
- March 6, 2020 · Voluntary: Firm initiated
- Classified
- March 25, 2020
- Reported
- April 1, 2020
- Ended
- April 1, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Theophylline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.